Search Results - "Lyckholm, Laurel"

Paradoxes in Advance Care Planning: The Complex Relationship of Oncology Patients, Their Physicians, and Advance Medical Directives by DOW, Lindsay A, MATSUYAMA, Robin K, RAMAKRISHNAN, V, KUHN, Laura, LAMONT, Elizabeth B, LYCKHOLM, Laurel, SMITH, Thomas J

“…Many seriously ill patients with cancer do not discuss prognosis or advance directives (ADs), which may lead to inappropriate and/or unwanted aggressive care…”
Get full text

Giving honest information to patients with advanced cancer maintains hope by Smith, Thomas J, Dow, Lindsay A, Virago, Enid, Khatcheressian, James, Lyckholm, Laurel J, Matsuyama, Robin

“…Oncologists often do not give honest prognostic and treatment-effect information to patients with advanced disease. One of the primary reasons stated for…”
Get more information

Navigating the Choppy Waters Between Public Safety and Humane Care of the Prisoner-Patient: The Role of the Ethics Consultant by Lyckholm, Laurel J., Shinkunas, Laura A.

Get full text

A pilot trial of decision aids to give truthful prognostic and treatment information to chemotherapy patients with advanced cancer by Smith, Thomas J, Dow, Lindsay A, Virago, Enid A, Khatcheressian, James, Matsuyama, Robin, Lyckholm, Laurel J

“…Most cancer patients do not have an explicit discussion about prognosis and treatment despite documented adverse outcomes. Few decision aids have been…”
Get more information

The Use of Octreotide to Manage Symptoms of Bronchorrhea: A Case Report by Pahuja, Meera, MD, MSc, Shepherd, Ray W., MD, Lyckholm, Laurel J., MD

“…Abstract Octreotide, a synthetic analogue of the hormone somatostatin, is primarily used in palliative medicine because of its antisecretory effect and has…”
Get full text

The end-of-life experience for a cohort of patients with pulmonary arterial hypertension by Grinnan, Daniel C, Swetz, Keith Mark, Pinson, Janet, Fairman, Paul, Lyckholm, Laurel J, Smith, Tom

“…Pulmonary arterial hypertension (PAH) is a progressive and ultimately fatal disease of the pulmonary circulation. There has never been an investigation of the…”
Get more information

A Problem of Capacity, but Whose? The Hospitalists' Discharge Dilemma and Social Determinants of Health by Mosher, Hilary J., Lyckholm, Laurel J.

Get full text

A Randomized, Placebo Controlled Trial of Oral Zinc for Chemotherapy-Related Taste and Smell Disorders by Lyckholm, Laurel, Heddinger, Steven P., Parker, Gwendolyn, Coyne, Patrick J., Ramakrishnan, Viswanathan, Smith, Thomas J., Henkin, Robert I.

“…ABSTRACT Abnormalities in taste and smell are commonly reported in patients receiving chemotherapy and may hinder appetite, dietary intake, nutritional…”
Get full text

Ethical Management of Patients with Cancer and Mental Illness by Lyckholm, Laurel J, Aburizik, Arwa K

“…Patients with co-existing cancer and mental illness must be given special attention due to the vulnerability that is created by their compromised psychological…”
Get more information

Shigella sonnei and hemolytic uremic syndrome: A case report and literature review by Adams, Casey, Vose, Aaron, Edmond, Michael B., Lyckholm, Laurel

“…Hemolytic uremic syndrome (HUS) is a well-described process that is known to cause severe renal dysfunction, thrombocytopenia, and anemia. HUS is typically…”
Get full text

A Case of Inaccurate Prognostication After the ARCTIC Protocol by Chen, Christina J., MD, Coyne, Patrick J., RN, MSN, FAAN, Lyckholm, Laurel J., MD, Smith, Thomas J., MD

“…Abstract Therapeutic hypothermia (ARCTIC, or Advanced Resuscitation Cooling Therapeutics and Intensive Care protocol) is a widely recommended intervention to…”
Get full text

Development of the CASH assessment tool to address existential concerns in patients with serious illness by Alesi, Erin R, Ford, Timothy R, Chen, Christina J, Fletcher, Devon S, Morel, Thomas D, Bobb, Barton T, Lyckholm, Laurel J

“…Existential suffering in patients with serious illness significantly impacts quality of life, yet it remains a challenge to define, assess, and manage…”
Get more information

Palliative Use of Aminocaproic Acid to Control Upper Gastrointestinal Bleeding by Roberts, Seth B., MD, PhD, Coyne, Patrick J., RN, MSN, Smith, Thomas J., MD, Lyckholm, Laurel J., MD

Get full text

Severe Lactic Acidosis in a Patient with B-Cell Lymphoma : A Case Report and Review of the Literature by Chan, Farn Huei, Carl, Daniel, Lyckholm, Laurel J.

“…Lactic acidosis is commonly observed in clinical situations such as shock and sepsis, as a result of tissue hypoperfusion and hypoxia. Lymphoma and leukemia…”
Get full text

'Futile care': what to do when your patient insists on chemotherapy that likely won't help by Khatcheressian, James, Harrington, Sara Beth, Lyckholm, Laurel J, Smith, Thomas J

“…While there is no generally accepted medical definition of "futile care," many factors may play a role in the delivery of chemotherapy to patients who are…”
Get more information

Development of a Palliative Care Fellows Quality Project Utilizing the PDSA Cycle: The CASH Paradigm for Evaluating Existential Distress (419-B) by Lyckholm, Laurel, MD, Alesi, Erin, MD, Chen, Christina, MD, Morel, Thomas, MD, Fletcher, Devon, MD, Coyne, Patrick, MSN APRN FAAN, Bobb, Bart, MSN FNP-BC ACHPN, Ford, Tim, MA MS CT

Get full text

Association of Hemophagocytic Lymphohistiocytosis and Programmed Death 1 Checkpoint Inhibitors by Laderian, Behnam, Koehn, Kelly, Holman, Carol, Lyckholm, Laurel, Furqan, Muhammad

Get more information

Panacea or Pandora's Box? Immune Checkpoint Inhibitors and Palliative Care (TH314) by Glisch, Chad, Lyckholm, Laurel J., Ray, James B., Hagiwara, Yuya

Get full text

Immune Checkpoint Inhibitor Use Near the End of Life Is Associated With Poor Performance Status, Lower Hospice Enrollment, and Dying in the Hospital by Glisch, Chad, Hagiwara, Yuya, Gilbertson-White, Stephanie, Gao, Yubo, Lyckholm, Laurel

“…Background: Immune checkpoint inhibitors have changed the landscape of cancer care by increasing progression-free and overall survival in some patients with…”
Get full text

Immune Checkpoint Inhibitor Use and Hospitalizations Near the End of Life (GP721) by Buzick, Justin, Chang, He, Shinkunas, Laura, Glisch, Chad, Lyckholm, Laurel, Hagiwara, Yuya

“…Outcomes. 1. Explain the role of immunotherapy in oncologic treatment 2. Understand the likelihood of oncologic follow-up and further cancer-directed therapy…”
Get full text